Evolve Biologics Establishes Sachse, Texas, Manufacturing Facility
12/17/2021
The new 200,000 sq. ft. location will initially have production capacity to process one million liters of plasma annually, with a planned expansion to two million liters.
“Today marks another significant milestone for Evolve as we take the next step towards the commercialization of our products and our goal of bringing critical plasma proteins to patients who need them,” said Jim Caggiano, CEO of Evolve. “Evolve’s patented next-generation technology, PlasmaCap EBA, is poised to revolutionize the plasma-derived therapeutics industry by harvesting significantly higher yields of these valuable proteins from human plasma through a cleaner, more efficient process, when compared to existing fractionation technologies. The state-of-the art Sachse facility, powered by our PlasmaCap EBA technology, will be the foundation of our future growth and global strategy.”
This state-of-the-art facility will be the first to use Evolve’s innovative and proprietary technology, PlasmaCap EBA, to commercially produce plasma-derived therapeutics, initially Intravenous Immunoglobulin and Human Serum Albumin.
“We are thrilled to welcome Evolve Biologics to Sachse as they grow to bring innovative therapeutic solutions to patients across the globe and deepen their roots here in Sachse,” added Gina Nash, City Manager for Sachse. “Evolve is a great addition to our local community, the region and the state of Texas. We welcome them as a neighbor, contributing to our local economy and supporting Texas’s continued growth, particularly in the biotechnology space.”
Project Announcements
Huber Engineered Woods Plans Shuqualak, Mississippi, Manufacturing Plant
06/09/2023
Gaffney Bakery Plans Gaffney, South Carolina, Frozen Bakery Products Plant
06/09/2023
Itron Establishes West Union, South Carolina, Center Of Excellence
06/09/2023
Devele Establishes Butte, Montana, Manufacturing Plant
06/09/2023
Manner Polymers Plans Mount Vernon, Illinois, Manufacturing Plant
06/09/2023
Purolite Establishes Landenberg, Pennsylvania, Global Biologics Division
06/08/2023
Most Read
-
EV and Semiconductor Projects Stand Out in States Receiving Area Development’s 18th Annual Shovel Awards
Q2 2023
-
Is a Flurry of Fads Shaping Economic Development Policy?
Q2 2023
-
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
Q1 2023
-
Front Line: Water Supply Increasingly Affecting Location Decisions
Q2 2023
-
Life Science Conversions in Real Estate
Q2 2023
-
Nearshoring — North America’s Next Factory
Q2 2023
-
First Person: Labor Crunch in the Construction Industry
Q2 2023